MaxLinear Heads Into Q3 Print With Sentiment Shifting

MXL heads into its October 21 Q3 earnings release with a stock that has moved violently in both directions and investors who are now leaning more bullish than defensive.

Options positioning reflects growing confidence rather than caution. The put/call ratio has dropped to 0.77, roughly 1.3 standard deviations below its 20-day average of 0.81. That shift toward calls is notable given the stock fell 13% over the past week to $77.11, even after bouncing 8% on Monday. The borrow market tells the same relaxed story: availability is extremely loose at 5,650%, meaning shares to borrow vastly outnumber those already shorted, and cost to borrow has fallen 61% over the past week to just 0.33%. Short interest at 5.5% of the free float has edged up 6% over the past month but drifted slightly lower over the past week. The lending market gives no sign of squeeze pressure.

The debate heading into the print centres on how far the infrastructure data center cycle can carry the company. Bulls point to Q2 revenue of $168.8 million, up 55% year over year, and Q3 guidance of $210 million to $220 million that came in well above expectations. The optical interconnect roadmap, including 1.6T products such as Rushmore, Washington, and Annapurna, gives a multi-year product narrative that most competitors cannot match at MaxLinear's scale. The analyst consensus is a buy, with a mean price target near $95 against a current price of $77. Stifel carries the most bullish view at $120, while Susquehanna and Wells Fargo sit closer to neutral, with targets of $80 and $95 respectively. Bears push back on demand visibility: satellite and cable providers can push out spending with little notice, DOCSIS adoption remains slow, and larger rivals including Broadcom and ADI compete aggressively on price. A legal overhang tied to a prior terminated deal, where the stated $160 million termination fee indicates potential liability, adds a tail risk that the revenue line alone does not capture.

One ownership signal is worth noting before the print. CEO Kishore Seendripu sold approximately $21 million worth of shares in August at prices between $84 and $88, none under a 10b5-1 plan. The stock has since retreated to $77. Those sales were not pre-arranged, which makes them more informative than a routine plan disposal, though the August timing followed a period of extraordinary stock performance and the CEO still holds around 5% of the company. T. Rowe Price added roughly 2.9 million shares in the most recent reported period, a meaningful fresh position that sits on the other side of the CEO's trim. The history around MXL earnings is itself a reason for caution on positioning: the July 2026 print produced a one-day drop of 17.5% and a five-day loss of 22.9%, a reminder that even strong guidance has not always protected the stock on the day.

The Q3 print will test whether the $210 million to $220 million guidance holds, and whether gross margins near 60% can survive the pricing pressure that bears have flagged from larger rivals.